Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Hubei Hongyuan Pharmaceutical Technology Co Ltd banner
H

Hubei Hongyuan Pharmaceutical Technology Co Ltd
SZSE:301246

Watchlist Manager
Hubei Hongyuan Pharmaceutical Technology Co Ltd
SZSE:301246
Watchlist
Price: 21.3 CNY 0.47% Market Closed
Market Cap: ¥5.7B
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one Hubei Hongyuan Pharmaceutical Technology Co Ltd stock under the Base Case scenario is 10.6 CNY. Compared to the current market price of 21.3 CNY, Hubei Hongyuan Pharmaceutical Technology Co Ltd is Overvalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
10.6 CNY
Overvaluation 50%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

Competitors Multiples
Hubei Hongyuan Pharmaceutical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hubei Hongyuan Pharmaceutical Technology Co Ltd
SZSE:301246
5.7B CNY 3.2 575 290.6 290.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 15.1 47.8 32.2 34.3
US
Johnson & Johnson
NYSE:JNJ
584.7B USD 6.2 21.8 15.2 18.6
CH
Roche Holding AG
SIX:ROG
291.9B CHF 4.8 31.1 13.1 15.3
UK
AstraZeneca PLC
LSE:AZN
238.4B GBP 5.6 32.1 17.7 24.9
CH
Novartis AG
SIX:NOVN
246.5B CHF 5.6 22.7 14 17.9
US
Merck & Co Inc
NYSE:MRK
301.7B USD 4.6 16.5 10.3 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.4 9.8 11.5
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
157.8B USD 2.5 20 7.4 10
UK
GSK plc
XETRA:GS71
104B EUR 2.8 15.8 8 11.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.